MedCity News June 28, 2022
In a wide-ranging discussion, Amwell Chairman & CEO Ido Schoenberg expressed frustration at being lumped together with other telehealth companies that have very different approaches and business models. But he was also very optimistic about the category overall.
It’s the best of times. It’s the worst of times — for telehealth companies, that is. No one category has seen its value in healthcare delivery be proven during the pandemic so much so that the digital transformation of healthcare has catapulted from nice-to-have to must-have. Yet, no other category has seen a reversal of fortune as it relates to stock prices of large, public telehealth...